Price$2.56-0.05 (-1.92%)
02:15 PM05:45 PM
News · 26 weeks35+100%
2026-04-192026-10-11
Mix1090d
- SEC Filings5(50%)
- Earnings2(20%)
- Other1(10%)
- Offering1(10%)
- Analyst1(10%)
Latest news
25 items- SECApyx Medical Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Apyx Medical Corp (0000719135) (Filer)
- ANALYSTMaxim Group initiated coverage on Apyx Medical with a new price targetMaxim Group initiated coverage of Apyx Medical with a rating of Buy and set a new price target of $6.00
- PRApyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin QualityCLEARWATER, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced results from a prospective clinical study evaluating the effects of Renuvion helium plasma radiofrequency technology on biological markers of skin quality. The study was published in Plastic and Reconstructive Surgery—Global Open 1. The study provides new human tissue evidence indicating that Renuvion treatment may produce measurable changes beneath the surface of the skin that support improvements in skin quality observed by physicians and
- SECApyx Medical Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Apyx Medical Corp (0000719135) (Filer)
- SECSEC Form 10-Q filed by Apyx Medical Corporation10-Q - Apyx Medical Corp (0000719135) (Filer)
- SECApyx Medical Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Apyx Medical Corp (0000719135) (Filer)
- PRApyx Medical Corporation Reports Second Quarter 2026 Financial ResultsReported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segmentSuccessful limited launch of the power liposuction handpiece for the AYON platform to key surgeons in critical geographies; initial commercial shipments in June 2026Reaffirmed total revenue guidance for FY2026 of $59.0 million to $60.0 millionManagement to host a conference call today at 4:30 p.m. ET CLEARWATER, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial
- PRApyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth ConferenceCLEARWATER, Fla., July 28, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that management will participate in the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, in Boston, MA. Charlie Goodwin, the Company’s President and Chief Executive Officer, and Matt Hill, the Company’s Chief Financial Officer, will participate in a fireside chat on Tuesday, August 11, 2026, at 2:30pm ET and will hold one-on-one meetings with investors throughout the day. The fireside chat will be accessible via
- SECSEC Form 8-K filed by Apyx Medical Corporation8-K - Apyx Medical Corp (0000719135) (Filer)
- PRApyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026CLEARWATER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that its financial results for the second quarter of fiscal year 2026 will be released after markets close on Thursday, August 6th. Management will host a conference call at 4:30 p.m. Eastern Time on Thursday, August 6th, to discuss the results of the quarter, followed by a question-and-answer session. To listen to the call by phone, interested parties may dial 800-717-1738 (or 646-307-1865 for international callers) and provide access code
- ANALYSTH.C. Wainwright initiated coverage on Apyx Medical with a new price targetH.C. Wainwright initiated coverage of Apyx Medical with a rating of Buy and set a new price target of $7.00
- INSIDERDirector Waldman Lawrence covered exercise/tax liability with 5,024 shares and exercised 12,000 shares at a strike of $1.88 (SEC Form 4)4 - Apyx Medical Corp (0000719135) (Issuer)
- SECSEC Form DEF 14A filed by Apyx Medical CorporationDEF 14A - Apyx Medical Corp (0000719135) (Filer)
- INSIDERChief Operating Officer Roman Shawn David exercised 15,000 shares at a strike of $3.23 and covered exercise/tax liability with 10,533 shares (SEC Form 4)4 - Apyx Medical Corp (0000719135) (Issuer)
- SECSEC Form 8-K filed by Apyx Medical Corporation8-K - Apyx Medical Corp (0000719135) (Filer)
- INSIDERSEC Form 4 filed by Director Levine Wendy Lauren4 - Apyx Medical Corp (0000719135) (Issuer)
- INSIDERDirector Vizirgianakis Stavros G. was granted 450,000 units of Restricted Stock Units, increasing direct ownership by 26% to 2,196,191 units (SEC Form 4)4 - Apyx Medical Corp (0000719135) (Issuer)
- INSIDERSEC Form 4 filed by Chief Executive Officer Goodwin Charles D. Ii4 - Apyx Medical Corp (0000719135) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Hill Matthew C4 - Apyx Medical Corp (0000719135) (Issuer)
- INSIDERSEC Form 4 filed by Chief Operating Officer Roman Shawn David4 - Apyx Medical Corp (0000719135) (Issuer)
- INSIDERSEC Form 4 filed by Sr. V.P. of Operations Citronowicz Moshe4 - Apyx Medical Corp (0000719135) (Issuer)
- INSIDERSEC Form 4 filed by Director Baylor-Henry Minnie4 - Apyx Medical Corp (0000719135) (Issuer)
- INSIDERSEC Form 4 filed by Director Waldman Lawrence4 - Apyx Medical Corp (0000719135) (Issuer)
- SECSEC Form SD filed by Apyx Medical CorporationSD - Apyx Medical Corp (0000719135) (Filer)
- PRBody by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the RunwayCLEARWATER, Fla., May 27, 2026 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), will return to Miami Swim Week with its Body by Apyx showcase, an immersive runway experience featuring real patient transformations. Building on last year's momentum, Apyx Medical has expanded its vision, introducing AYON, the next generation body contouring system designed to bring together the technologies surgeons rely on most into one comprehensiv
APYX FAQ
6 questionsWhat does Apyx Medical Corporation do?
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded...Where does APYX stock trade?
Apyx Medical Corporation (APYX) is listed on NASDAQ.What sector and industry is APYX in?
Apyx Medical Corporation operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about APYX?
Apyx Medical Corporation has had 8 recent analyst actions on file. The most recent action was from Maxim Group: Buy with a $600.00 price target on 2026-09-29. Recent price targets range from $600.00 to $800.00.What companies are similar to APYX?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare APYX side-by-side with any of them on Quantisnow.How can I track APYX on Quantisnow?
Quantisnow aggregates Apyx Medical Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow APYX to receive live email and push alerts on every new disclosure.